BD and FIND Achieve Milestone in Global Battle Against MDR-TB
... be used as near as possible to where patients first seek care. FIND's disease portfolio currently includes tuberculosis, malaria and human African trypanosomiasis and current donors are the Bill & Melinda Gates Foundation, the European Union, the Government of the Netherlands, UNITAID, Irish Aid and other ...Immtech Announces Pafuramidine (DB289) Program on Clinical Hold
... to treat infectious diseases. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting hepatitis C, fungal infections, and bacterial infections. ...Immtech Completes Malaria Prevention Trial
... to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal ...Sleeping Sickness Comes to India
... The first case of human trypanosomiasis has now been discovered in India. Sleeping ... identified as the first confirmed case of human trypanosomiasis recorded in this country. Human ... a specialist in the African form of human trypanosomiasis (sleeping sickness), undertook the identification ...Understanding Sleeping Sickness
... Sleeping sickness or Human African trypanosomiasis is caused by the bite of an insect , called the glossinid tse-tse fly//, which passes on the parasite called the trypanosome, to human beings through ...$68 million aid pours in from Gates Foundation to fight tropical diseases
... announced four grants totaling to more than $68.2 million. This fund will assist in controlling three diseases - hookworm, leishmaniasis and trypanosomiasis – which are spread by parasites and worms. These worms are lethal in that they could impair child growth and development for life. Presently ...Sleeping sickness - a silent killer
... scientists say free drugs are not enough. According to WHO estimates, some half a million people in Africa are currently infected by African trypanosomiasis - but because of a lack of medical screening in rural areas, many do not even know they have the disease until it is too late. If untreated the ...Immtech Announces Posting of Annual Shareholders Meeting Presentation
... drugs to treat infectious diseases. Immtech has advanced clinical programs that include new treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting Hepatitis C, fungal infections, and bacterial infections. ...Immtech Reports Fiscal Second Quarter 2008 Results
... to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness or HAT), and a well-defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal ...Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
... to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well-defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal ...Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
... to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal ...Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
... to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well defined, growing library of compounds targeting drug-resistant Gram-positive bacteria, fungal ...General Wesley Clark Joins Immtech as Consulting Strategic Advisor
... drugs to treat infectious diseases. Immtech has advanced clinical programs that include new treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting Hepatitis C, fungal infections, and bacterial infections. ...Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
... to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for Pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting fungal infections, Hepatitis C and other serious diseases. ...The insect vector always bites twice
... transmission by mosquitoes of the genus Anopheles and human African trypanosomiasis (sleeping sickness) by Glossinia species or tsetse flies, revealed that ... of the disease. The objective of the work conducted on human African trypanosomiasis was to analyse the antibody response to identify exactly, in total saliva ...Compound might defeat African sleeping sickness, clinical trial beginning this month
... the tsetse fly-borne infection rivals or exceeds the toll AIDS takes. trypanosomiasis is passed from human to human by tsetse fly bites. It produces fever, ... Michael Barrett at the University of Glasgow, Raymond Mdachi at Kenya trypanosomiasis Research Institute and Steven Meshnick and J. Ed Hall of UNC. Scientists ...UCSF researchers help crack parasite genome, identify drug leads
... targets in many parasites and that small-molecule protease inhibitors can limit or cure experimental infections of Chagas' disease, Human African trypanosomiasis and schistosomiasis. The detailed characterization of the S. mansoni degradome, therefore, may similarly lead to the identification and development ...BD and FIND Achieve Milestone in Global Battle Against MDR-TB
... be used as near as possible to where patients first seek care. FIND's disease portfolio currently includes tuberculosis, malaria and human African trypanosomiasis and current donors are the Bill & Melinda Gates Foundation, the European Union, the Government of the Netherlands, UNITAID, Irish Aid and other ...Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine
... to treat infectious diseases. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (African sleeping sickness), and a well defined, expanding library of compounds targeting hepatitis C, fungal infections, and bacterial infections. ...Immtech to Present at The Bank of Montreal Healthcare Conference
... to treat other disorders. Immtech has advanced clinical programs that include new oral treatments for pneumocystis pneumonia (PCP), malaria, and trypanosomiasis (HAT or African sleeping sickness), and a well defined, expanding library of compounds targeting drug-resistant Gram-positive bacteria, fungal ...